This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Wakunaga Pharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Masayuki Sato: Innovator in Antitumor Compounds
Introduction
Masayuki Sato is a notable inventor based in Akitakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with potential antitumor properties. His work is characterized by a commitment to creating innovative solutions that address critical health challenges.
Latest Patents
Masayuki Sato holds a patent for a pyridone carboxylic acid derivative or salt thereof. This invention aims to provide a novel compound that exhibits high antitumor activity while maintaining low toxicity to normal cells. The compound is represented by a specific chemical formula, which includes various substituents that enhance its therapeutic potential.
Career Highlights
Sato is currently associated with Wakunaga Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical compounds that contribute to cancer treatment.
Collaborations
Some of his notable coworkers include Tatsuya Hirano and Taichi Ueshima. Their collaborative efforts have further enriched the research environment at Wakunaga Pharmaceutical Co., Ltd.
Conclusion
Masayuki Sato's innovative work in developing antitumor compounds highlights his dedication to improving healthcare outcomes. His contributions to the field of pharmaceuticals are commendable and reflect the importance of ongoing research in combating cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile